Listen to concise summaries from FITs from the University of Michigan, with commentary from ACC.org Editor-in-Chief Kim A. Eagle, MD, MACC, on the most impactful late-breaking clinical trials from ACC.23/WCC. Trials include CLEAR Outcomes, Oral PCSK9 Inhibitor MK-0616, STELLAR, PULSED-AF, RAPID-HF, FREEDOM-COVID, TRILUMINATE Pivotal, LIVE-HCM, Return to Play, BETTER CARE HF, COAPT 5-Year Follow Up, STOP-CA and Wrist-Worn Transdermal TnI Sensor. Watch the on-demand webinar here.